Srinivasan, Sundararajan
Severa, Martina
Rizzo, Fabiana
Menon, Ramesh
Brini, Elena
Mechelli, Rosella
Martinelli, Vittorio
Hertzog, Paul
Salvetti, Marco
Furlan, Roberto http://orcid.org/0000-0001-7376-9425
Martino, Gianvito http://orcid.org/0000-0003-1295-9131
Comi, Giancarlo
Coccia, Eliana M.
Farina, Cinthia
Article History
Received: 23 May 2017
Accepted: 18 July 2017
First Online: 21 August 2017
Change Date: 11 May 2018
Change Type: Correction
Change Details: A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Competing Interests
: Sundararajan Srinivasan, Martina Severa, Fabiana Rizzo, Ramesh Menon, Elena Brini, Rosella Mechelli, Paul Hertzog, Eliana M. Coccia declare no conflict of interest. Vittorio Martinelli received speaking honoraria, consultancy fee and travel support from Bayer, Biogen-Idec, Merck-Serono, Novartis, Genzyme and Teva. Marco Salvetti received lecture fees and research support from Biogen, Bayer-Schering, Biogen-Dompé, Merck-Serono, Sanofi-Aventis, Teva. Roberto Furlan received speaker honoraria from Merck Serono, Novartis and Roche, and research support from EMD Serono. Gianvito Martino received speaker honoraria from Biogen Idec, Merck Serono; travel and research support from Merck Serono, Teva. Giancarlo Comi received speaker honoraria, consultancy fees from Novartis, Teva, Sanofi, Genzyme, Merck, Biogen, Excemed, Roche, Almirall, Receptors and Forward Pharm. Cinthia Farina received research support from Merck-Serono, Teva, Novartis.